Thumbnail

欧洲胰岛素输送设备市场 - 按类型(笔、胰岛素泵、胰岛素注射器等)细分 - 增长、趋势、COVID-19 影响和预测(2021 - 2026 年)

Looking to buy the report?

糖尿病患病率的增加和输送系统的技术进步:

欧洲地区所有年龄段的糖尿病患病率都在增加,这主要是由于肥胖、不健康的饮食和缺乏身体活动。欧洲自身免疫性 1 型糖尿病的发病率也在上升,该地区的 1 型糖尿病儿童人数最多。对儿童 1 型糖尿病总数贡献最大的欧洲国家是英国、俄罗斯联邦和德国。这导致了对胰岛素的大量需求。德国在胰岛素输送设备市场上占据主导地位。虽然 2 型糖尿病患者的治疗是从口服药物开始的,但由于不健康的生活方式导致血糖水平不能很好地控制时,也需要使用胰岛素。因此,2型糖尿病患者甚至存在对胰岛素市场的需求,这直接显示了对胰岛素输送设备市场的影响。此外,各国政府正在采取措施提高人们对糖尿病护理的认识,这反过来又会提高人们的认识,并将导致被诊断出糖尿病的人数增加。

 随着技术的进步,为需要更严格控制血糖和血红蛋白 A1c 水平 (HbA1C) 的患者发现了一种更好的胰岛素给药方式,从而减少了与糖尿病相关的长期并发症的机会。其中一项进步是通过胰岛素泵输送胰岛素,其价格高于胰岛素注射给药装置(注射器和笔),并且非常复杂。喷射注射器是设备,它们是无针胰岛素设备。喷射注射器使用高压液体药物射流穿透皮肤并在皮肤下输送和沉积药物,无需针头。

天价压力:

许多使用胰岛素注射器或胰岛素笔的患者每次注射后不更换针头,这将有助于减轻糖尿病的经济负担。但患者没有意识到的事实是,任何注射器的重复使用都会导致针尖畸形并在注射下一剂时增加疼痛。它还可能导致皮肤感染。胰岛素泵及其用品可能比用于注射胰岛素的注射器贵得多,几个胰岛素泵的成本超过 5000 美元;必要用品的成本可能超过 100 美元。使用胰岛素泵的另一个缺点是,如果泵出现故障,发生糖尿病酮症酸中毒的风险更高。喷射注射器的低意识和高价格也是胰岛素输送设备市场面临的限制之一。

市场的主要发展:

2018 年 9 月: SFC Fluidics 开发胰岛素贴片泵。SFC Fluidics 表示,它从美国国立卫生研究院的国家糖尿病、消化和肾脏疾病研究所获得了 140 万美元的拨款,用于开发一种可以在小型系统中输送胰岛素和胰高血糖素的贴片泵。

关键人物;主力;重要一员:

诺和诺德、赛诺菲、礼来、Animas Corporation、Insulet Corporation、Medtronics, Inc.、Ypsomed、罗氏和 Tandem 糖尿病护理,以及 Becton Dickenson,Insujet。

报告范围:

属性

细节

估计的基准年

2017<

/p>

审查期

2012-2017

预测期

2018 – 2023

市场代表

2018 年至 2023 年的百万美元收入和复合年增长率

覆盖地区

欧洲

报告覆盖率

收入预测和市场动态

购买本报告的理由

  • 欧洲胰岛素输送设备市场的当前和未来展望。
  • 借助波特五力分析分析市场的各种观点
  • 预计将主导市场的细分市场
  • 预计在预测期内增长最快的地区
  • 确定主要市场参与者采用的最新发展和策略。
  • 3 个月的分析师支持以及市场评估表(Excel 格式)。

报告的定制

该报告可以定制以满足您的要求。请与我们的代表联系,他们将确保您获得适合您需求的报告。

1. Introduction

                1.1 Scope of Study

                1.2 Market Definition

                1.3 Executive Summary

2. Research Methodology

                2.1 Study Deliverables

                2.2 Study Assumptions

                2.3 Research Phases

3. Market Insights

                3.1 Technology Trends

                3.2 Industry Attractiveness - Porter's Five Forces Analysis

                                3.2.1 Bargaining Power of the Suppliers

                                3.2.2 Bargaining Power of the Consumers

                                3.2.3 Threat of New Entrants

                                3.2.4 Threat of Substitute Products and Services

                                3.2.5 Competitive Rivalry within the Industry

4.  Market Dynamics

                4.1 Drivers

                4.2 Restraints

                4.3 Opportunities

5. Market Segmentation and Analysis

                5.1 Management Device

                                5.1.1 Insulin Pump

                                                5.1.1.1 Insulin Pump Device

                                                                5.1.1.1.1 Insulin Pump Devices, Revenue (2012-2023)

                                                                5.1.1.1.2 Insulin Pump Devices, Volume (2012-2023)

                                                5.1.1.2 Insulin Pump Reservoir

                                                                5.1.1.2.1 Insulin Pump Reservoirs, Revenue (2012-2023)

                                                                5.1.1.2.2 Insulin Pump Reservoirs, Volume (2012-2023)

                                                5.1.1.3 Infusion Set

                                                                5.1.1.3.1 Infusion Sets, Revenue (2012-2023)

                                                                5.1.1.3.2 Infusion Sets, Volume (2012-2023)

                                5.1.2 Syringes

                                                5.1.2.1 Syringes, Revenue (2012-2023)

                                                5.1.2.2 Syringes, Volume (2012-2023)

                                5.1.3 Cartridges

                                                5.1.3.1 Cartridges, Revenue (2012-2023)

                                                5.1.3.2 Cartridges, Volume (2012-2023)

                                5.1.4 Disposable Pens

                                                5.1.4.1 Disposable Pens, Revenue (2012-2023)

                                                5.1.4.2 Disposable Pens, Volume (2012-2023)

                                5.1.5 Jet Injectors

                                                5.1.5.1 Jet Injectors, Revenue (2012-2023)

                                                5.1.5.2 Jet Injectors, Volume (2012-2023)

6. Market Analysis

                6.1 Europe

                                6.1.1 France

                                                6.1.1.1 France, Revenue (2012-2023)

                                                6.1.1.2 France, Volume (2012-2023)

                                6.1.2 Germany

                                                6.1.2.1 Germany, Revenue (2012-2023)

                                                6.1.2.2 Germany, Volume (2012-2023)

                                6.1.3 Italy

                                                6.1.3.1 Italy, Revenue (2012-2023)

                                                6.1.3.2 Italy, Volume (2012-2023)

                                6.1.4 Russia

                                                6.1.4.1 Russia, Revenue (2012-2023)

                                                6.1.4.2 Russia, Volume (2012-2023)

                                6.1.5 Spain

                                                6.1.5.1 Spain, Revenue (2012-2023)

                                                6.1.5.2 Spain, Volume (2012-2023)

                                6.1.6 United Kingdom (UK)

                                                6.1.6.1 UK, Revenue (2012-2023)

                                                6.1.6.2 UK, Volume (2012-2023)

                                6.1.7 Rest of Europe

                                                6.1.7.1 Rest of Europe, Revenue (2012-2023)

                                                6.1.7.2 Rest of Europe, Volume (2012-2023)

7. Competitive Landscape

                7.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

8. Key Player Profiles

                8.1 Novo Nordisk

                8.2 Sanofi

                8.3 Eli Lilly

                8.4 Becton and Dickinson

                8.5 Medtronics

                8.6 Insulet

                8.7 Animas

                8.8 Tandem Diabetes care

                8.9 Insujet

* Each Company Profile include overview, Revenue, Product and services, SWOT, Recent Activities and strategic Analysis.

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy